The Food and Drug Administration said Wednesday it approved changes to the license for a critical monkeypox vaccine, clearing the way for 786,000 doses to be distributed in the U.S.
Regulators amended the biologics license for the Jynneos vaccine manufactured by Bavarian Nordic.
Release of the doses is viewed as a critical step in the monkeypox response as New York City and other locales complain they are running out of vaccine doses swiftly, sparking anger in the hard-hit LGBT community and frustration among medical professionals.
Health and Human Services Secretary Xavier Becerra applauded the FDA’s action.